Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Undoing SUMO aids polyQ AR

Andrew P Lieberman1, Jorge A Iniguez-Lluhi2

  • 1Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.

Oncotarget
|October 3, 2015
PubMed
Summary

No abstract available in PubMed .

Keywords:
SUMOandrogen receptorpolyglutaminespinal and bulbar muscular atrophy

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sleep fragmentation correlates with amyloid beta deposition at brain autopsy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

PGC-1α pathway dysregulation disrupts myofiber specification in a mouse model of SBMA.

JCI insight·2026
Same author

FGFR1:TACC1-Fused Pilocytic Astrocytoma in a Child With Muenke Syndrome: A Case Report.

Pediatric blood & cancer·2026
Same author

CTE-Type Tau Filaments in Alzheimer's Disease with Co-morbid LATE-NC.

bioRxiv : the preprint server for biology·2025
Same author

PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2025
Same author

Peripherally administered androgen receptor-targeted antisense oligonucleotide rescues spinal pathology in a murine SBMA model.

The Journal of clinical investigation·2025
Same journal

Retraction: Long noncoding RNA XIST is a prognostic factor in colorectal cancer and inhibits 5-fluorouracil-induced cell cytotoxicity through promoting thymidylate synthase expression.

Oncotarget·2026
Same journal

TRAIL-R2 in the shadows: Epigenetic silencing and clinical implications in breast cancer.

Oncotarget·2026
Same journal

Retraction: MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.

Oncotarget·2026
Same journal

Laryngeal leiomyosarcoma: A rare case report and literature review.

Oncotarget·2026
Same journal

Correction: Postsurgery fluids promote transition of cancer stem cell toendothelial and AKT/mTOR activity contributing to relapse of giant cell tumors of bone.

Oncotarget·2026
Same journal

DHHC3 interferes with antitumor immunity in melanoma cells.

Oncotarget·2026
See all related articles